Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cocaine-associated chest pain

Michael B Erwin1, Efthymios N Deliargyris

  • 1Cardiology Section, Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina 27157-1045, USA.

The American Journal of the Medical Sciences
|July 18, 2002
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug Clearance and Dosing During CytoSorb Hemoadsorption: A Systematic Review.

Critical care explorations·2026
Same author

The International, Prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: Interim Results in Patients with Septic Shock.

Annals of intensive care·2026
Same author

The international, prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: results from the first 300 patients.

Journal of anesthesia, analgesia and critical care·2026
Same author

Pharmacokinetic Modeling of Ticagrelor and Ticagrelor Active Metabolite Removal by the DrugSorb-ATR Device in a Randomized Controlled Study of Patients Undergoing Cardiac Surgery.

Journal of cardiovascular pharmacology·2026
Same author

Randomized, sham-controlled trial of intraoperative ticagrelor removal to reduce perioperative bleeding.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Hemoadsorption therapy in severe rhabdomyolysis: a report from the international, prospective COSMOS (CytOSorb<sup>®</sup> TreatMent of Critically ill PatientS) registry.

Renal failure·2025